Baidu
map

门脉高压患者门体支架植入围术期营养管理专家共识(2020)

2021-03-28 中国医师协会介入医师分会 介入放射学杂志.2021.30(3):217-224.

为促进门脉高压经颈静脉肝内门体分流术(TIPS)围术期患者营养管理标准化和规范化,改善患者生活质量及预后, 中国医师协会介入医师分会介入围手术专委会组织国内TIPS 护理专家撰写本共识。本共识系统总结

中文标题:

门脉高压患者门体支架植入围术期营养管理专家共识(2020)

发布日期:

2021-03-28

简要介绍:

为促进门脉高压经颈静脉肝内门体分流术(TIPS)围术期患者营养管理标准化和规范化,改善患者生活质量及预后, 中国医师协会介入医师分会介入围手术专委会组织国内TIPS 护理专家撰写本共识。本共识系统总结了国内外相关文献,并结合我国门脉高压的临床实践,就门脉高压患者门体支架植入围术期的营养管理问题从筛查与评估、营养干预支持、监测与评定、出院指导、随访进行了初步论述,旨在为TIPS 围术期营养管理提供指导与参考。

相关资料下载:
[AttachmentFileName(sort=1, fileName=门脉高压患者门体支架植入围术期营养管理专家共识_2020_李国宏.pdf)] GetToolGuiderByIdResponse(projectId=1, id=6d4911c0020811b9, title=门脉高压患者门体支架植入围术期营养管理专家共识(2020), enTitle=, guiderFrom=介入放射学杂志.2021.30(3):217-224., authorId=0, author=, summary=为促进门脉高压经颈静脉肝内门体分流术(TIPS)围术期患者营养管理标准化和规范化,改善患者生活质量及预后, 中国医师协会介入医师分会介入围手术专委会组织国内TIPS 护理专家撰写本共识。本共识系统总结, cover=https://img.medsci.cn/2021410/1618060008228_2020535.jpg, journalId=0, articlesId=null, associationId=1299, associationName=中国医师协会介入医师分会, associationIntro=, copyright=0, guiderPublishedTime=Sun Mar 28 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <div class="one_info2"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>为促进门脉高压经颈静脉肝内门体分流术(TIPS)围术期患者营养管理标准化和规范化,改善患者生活质量及预后, 中国医师协会介入医师分会介入围手术专委会组织国内TIPS 护理专家撰写本共识。本共识系统总结了国内外相关文献,并结合我国门脉高压的临床实践,就门脉高压患者门体支架植入围术期的营养管理问题从筛查与评估、营养干预支持、监测与评定、出院指导、随访进行了初步论述,旨在为TIPS 围术期营养管理提供指导与参考。</p> </div> </div> </div> </div> </div> </div>, tagList=[TagDto(tagId=3446, tagName=门脉高压)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=22, categoryName=肝病, tenant=100), CategoryDto(categoryId=66, categoryName=营养科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=3446, guiderKeyword=门脉高压, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=28630, appHits=106, showAppHits=0, pcHits=627, showPcHits=28524, likes=1, shares=18, comments=10, approvalStatus=1, publishedTime=Sat Apr 10 21:09:10 CST 2021, publishedTimeString=2021-03-28, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat Apr 10 21:06:54 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 22:43:01 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=门脉高压患者门体支架植入围术期营养管理专家共识_2020_李国宏.pdf)])
门脉高压患者门体支架植入围术期营养管理专家共识_2020_李国宏.pdf
下载请点击:
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1082375, encodeId=04e610823e50c, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:45:11 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967554, encodeId=d42296e554f1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0694855030, createdName=chineselining, createdTime=Fri May 21 17:15:10 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967552, encodeId=61ff96e552d0, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0694855030, createdName=chineselining, createdTime=Fri May 21 17:14:25 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967493, encodeId=667696e49351, content=学习了很多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210521/39805f6cf9fc4f4ab1c51a45735c7b02/dab272923f7540668d6a78dbd24a26a8.jpg, createdBy=71515505707, createdName=ms6000001175723702, createdTime=Fri May 21 15:50:04 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960663, encodeId=793e9606630e, content=学习了,很有价值, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210426/763e7ce2dab140888e41ebc5fca8c4b7/61843205f4d644369d57d751f29054a3.jpg, createdBy=8ba35478954, createdName=ms9000000883963153, createdTime=Mon Apr 26 15:28:46 CST 2021, time=2021-04-26, status=1, ipAttribution=)]
    2021-12-21 龙珠

    学习好资料!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1082375, encodeId=04e610823e50c, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:45:11 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967554, encodeId=d42296e554f1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0694855030, createdName=chineselining, createdTime=Fri May 21 17:15:10 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967552, encodeId=61ff96e552d0, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0694855030, createdName=chineselining, createdTime=Fri May 21 17:14:25 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967493, encodeId=667696e49351, content=学习了很多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210521/39805f6cf9fc4f4ab1c51a45735c7b02/dab272923f7540668d6a78dbd24a26a8.jpg, createdBy=71515505707, createdName=ms6000001175723702, createdTime=Fri May 21 15:50:04 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960663, encodeId=793e9606630e, content=学习了,很有价值, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210426/763e7ce2dab140888e41ebc5fca8c4b7/61843205f4d644369d57d751f29054a3.jpg, createdBy=8ba35478954, createdName=ms9000000883963153, createdTime=Mon Apr 26 15:28:46 CST 2021, time=2021-04-26, status=1, ipAttribution=)]
    2021-05-21 chineselining

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1082375, encodeId=04e610823e50c, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:45:11 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967554, encodeId=d42296e554f1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0694855030, createdName=chineselining, createdTime=Fri May 21 17:15:10 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967552, encodeId=61ff96e552d0, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0694855030, createdName=chineselining, createdTime=Fri May 21 17:14:25 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967493, encodeId=667696e49351, content=学习了很多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210521/39805f6cf9fc4f4ab1c51a45735c7b02/dab272923f7540668d6a78dbd24a26a8.jpg, createdBy=71515505707, createdName=ms6000001175723702, createdTime=Fri May 21 15:50:04 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960663, encodeId=793e9606630e, content=学习了,很有价值, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210426/763e7ce2dab140888e41ebc5fca8c4b7/61843205f4d644369d57d751f29054a3.jpg, createdBy=8ba35478954, createdName=ms9000000883963153, createdTime=Mon Apr 26 15:28:46 CST 2021, time=2021-04-26, status=1, ipAttribution=)]
    2021-05-21 chineselining

    好文章

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1082375, encodeId=04e610823e50c, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:45:11 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967554, encodeId=d42296e554f1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0694855030, createdName=chineselining, createdTime=Fri May 21 17:15:10 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967552, encodeId=61ff96e552d0, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0694855030, createdName=chineselining, createdTime=Fri May 21 17:14:25 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967493, encodeId=667696e49351, content=学习了很多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210521/39805f6cf9fc4f4ab1c51a45735c7b02/dab272923f7540668d6a78dbd24a26a8.jpg, createdBy=71515505707, createdName=ms6000001175723702, createdTime=Fri May 21 15:50:04 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960663, encodeId=793e9606630e, content=学习了,很有价值, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210426/763e7ce2dab140888e41ebc5fca8c4b7/61843205f4d644369d57d751f29054a3.jpg, createdBy=8ba35478954, createdName=ms9000000883963153, createdTime=Mon Apr 26 15:28:46 CST 2021, time=2021-04-26, status=1, ipAttribution=)]
    2021-05-21 ms6000001175723702

    学习了很多

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1082375, encodeId=04e610823e50c, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:45:11 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967554, encodeId=d42296e554f1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0694855030, createdName=chineselining, createdTime=Fri May 21 17:15:10 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967552, encodeId=61ff96e552d0, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0694855030, createdName=chineselining, createdTime=Fri May 21 17:14:25 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967493, encodeId=667696e49351, content=学习了很多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210521/39805f6cf9fc4f4ab1c51a45735c7b02/dab272923f7540668d6a78dbd24a26a8.jpg, createdBy=71515505707, createdName=ms6000001175723702, createdTime=Fri May 21 15:50:04 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960663, encodeId=793e9606630e, content=学习了,很有价值, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210426/763e7ce2dab140888e41ebc5fca8c4b7/61843205f4d644369d57d751f29054a3.jpg, createdBy=8ba35478954, createdName=ms9000000883963153, createdTime=Mon Apr 26 15:28:46 CST 2021, time=2021-04-26, status=1, ipAttribution=)]
    2021-04-26 ms9000000883963153

    学习了,很有价值

    0

拓展阅读

2020 BSG指南:经颈静脉肝内门体静脉内支架分流术(TIPSS)治疗门脉高压

英国胃肠病学会(BSG,British Society of Gastroenterology) · 2020-02-29

AISF临床实践指南:门脉高压和腹水

意大利肝病学会(AISF,Italian Association for the Study of the Liver) · 2021-07-25

2021 AISF临床实践指南:门脉高压和腹水

意大利肝病学会(AISF,Italian Association for the Study of the Liver) · 2021-09-05

Baveno第七届共识会议建议:肝硬化门脉高压诊断和管理的最新进展

西班牙消化病理学会(Spanish Society of Digestive Pathology) · 2022-08-26

Baidu
map
Baidu
map
Baidu
map